1 Min Read
Dec 19 (Reuters) - Medicure Inc:
* MEDICURE INC SAYS CARMEL BIOSCIENCES RECEIVED FINAL APPROVAL OF ITS NDA FROM U.S. FDA FOR PREXXARTAN (VALSARTAN) ORAL SOLUTION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.